Question

What is not true about the first product from a genetically engineered (pharmed) animal to be approved by the FDA?

-The recombinant protein is mainly expressed in the mammary glands
-The recombinant product is human antithrombin
-The product is designed to inhibit blood clotting in patients deficient in the protein
-A functional human gene was knocked into a camel's genome
-The rDNA introduced is regulated as a drug because it affects the biological functions of the engineered animal

Answer 1

The incorrect statement about the first FDA-approved product from a genetically engineered animal is that a human gene was inserted into the genome of a camel; in fact, it was a goat that produced the antithrombin protein.

Step-by-step explanation:

The statement that is not true about the first product from a genetically engineered (pharmed) animal to be approved by the FDA is that4) 'a functional human gene was knocked into a camel's genome'.

In reality, the first FDA-approved product from a genetically engineered animal was antithrombin, a recombinant protein expressed mainly in the mammary glands of transgenic goats, not camels.

The product, called ATryn, is designed to inhibit blood clotting in patients deficient in antithrombin.

The recombinant DNA (rDNA) introduced into the goats is indeed regulated as a drug because it affects the biological functions of the engineered animal.